1,800
Views
3
CrossRef citations to date
0
Altmetric
Neurology

Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 669-678 | Received 04 Apr 2022, Accepted 12 May 2022, Published online: 27 May 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.